RhumbLine Advisers’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $7.8K | Hold |
|
|||||
|
2023
Q4 | $6.95K | Hold |
|
|||||
|
2023
Q3 | $4.11K | Sell |
|
|||||
|
2023
Q2 | $13.9K | Sell |
|
|||||
|
2023
Q1 | $327K | Buy |
|
|||||
|
2022
Q4 | $281K | Buy |
|
|||||
|
2022
Q3 | $547K | Buy |
|
|||||
|
2022
Q2 | $542K | Buy |
|
|||||
|
2022
Q1 | $361K | Buy |
|
|||||
|
2021
Q4 | $536K | Buy |
|
|||||
|
2021
Q3 | $690K | Buy |
|
|||||
|
2021
Q2 | $360K | Buy |
|
|||||
|
2021
Q1 | $364K | Buy |
|